Cymbalta (Duloxetine): Clinical Uses and Side Effects
FDA-Approved Indications
Cymbalta (duloxetine) is FDA-approved for major depressive disorder, generalized anxiety disorder (adults and children ≥7 years), diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain in adults. 1
Primary Clinical Uses
Neuropathic Pain Conditions
- Duloxetine 60 mg daily is the most effective dose for diabetic peripheral neuropathy, achieving ≥50% pain reduction in significantly more patients than placebo (risk ratio 1.73) with a number needed to treat of 5 2
- For painful diabetic neuropathy specifically, duloxetine demonstrates sustained efficacy up to one year in open-label trials 2
- The American Diabetes Association recommends duloxetine as a first-line medication for neuropathic pain, particularly diabetic peripheral neuropathy 2
- Duloxetine shows more pronounced effectiveness in platinum-based chemotherapy-induced neuropathy compared to taxane-induced neuropathy 3
Chronic Musculoskeletal Pain
- For chronic knee osteoarthritis, duloxetine 60 mg daily is recommended as second-line treatment when topical NSAIDs are insufficient or when multiple joints are affected 3, 2
- Duloxetine demonstrates small to moderate benefits for pain and function at 3-6 months and 6-12 months in knee osteoarthritis 2
- Evidence shows greater effectiveness in older patients (>65 years) and specifically in knee osteoarthritis compared to hip osteoarthritis 2
- For chronic low back pain with insufficient response to exercise and physical therapy, duloxetine provides small improvements and can be considered for patients without contraindications 3
Fibromyalgia
- Duloxetine 60-120 mg daily produces small to moderate improvements in pain, function, and quality of life in fibromyalgia patients 3
- The risk ratio for ≥50% pain reduction at 12 weeks is 1.57 with a number needed to treat of 8 2
- Duloxetine is FDA-approved and recommended as first-line treatment for fibromyalgia 3
Psychiatric Conditions
- Duloxetine is effective for major depressive disorder and generalized anxiety disorder in adults 1, 4
- For patients with co-occurring chronic pain and depression, duloxetine may provide dual benefits as depression can exacerbate physical pain symptoms 3
Dosing and Administration
Standard Dosing Protocol
- Start with 30 mg once daily for one week, then increase to 60 mg once daily to minimize nausea 2
- Maximum effect for pain conditions typically requires 60 mg daily 2
- For pain management, 60 mg once daily appears as effective as 60 mg twice daily 2
- Duloxetine can be taken with or without food 1
- Swallow capsules whole—do not chew, crush, open, or mix contents with food or liquids 1
Special Populations
- In older adults (≥65 years), adverse events may be more severe but can be attenuated with lower doses and slower titration 3, 2
- Unlike tricyclic antidepressants, duloxetine does not produce clinically important electrocardiographic changes or blood pressure alterations, making it safer for older adults 2
Discontinuation
- Duloxetine must be tapered over at least 2-4 weeks for patients treated longer than 3 weeks to avoid withdrawal symptoms 2
- Never stop duloxetine abruptly without consulting the prescribing provider 2
Side Effects
Most Common Adverse Effects
The most frequent side effects include 1:
- Nausea (most common—can be reduced by starting at 30 mg daily) 2
- Dry mouth
- Sleepiness and fatigue
- Constipation
- Loss of appetite
- Increased sweating
- Dizziness
Serious Adverse Effects Requiring Monitoring
Blood pressure changes and falls 1:
- May increase blood pressure—monitor before starting and throughout treatment
- Can cause orthostatic hypotension with dizziness or fainting, especially when initiating or increasing dose
- Increased fall risk, particularly in elderly patients
Liver damage 1:
- Symptoms include itching, right upper abdominal pain, dark urine, jaundice, enlarged liver
- Avoid heavy alcohol use while taking duloxetine as concomitant use may cause severe liver injury 1
Serotonin syndrome (potentially life-threatening) 1:
- Symptoms: agitation, hallucinations, coordination problems, muscle twitching, racing heartbeat, blood pressure changes, fever, nausea, vomiting, diarrhea, muscle rigidity, tremor, seizures
- Risk increased when combined with other serotonergic drugs (SSRIs, SNRIs, MAOIs, triptans, tramadol, fentanyl, amphetamines) 1
Abnormal bleeding 1:
- Increased risk when combined with warfarin, NSAIDs, or aspirin 1
Hyponatremia 1:
- Elderly patients at greater risk
- Symptoms: headache, weakness, unsteadiness, confusion, memory problems
Other serious effects 1:
- Severe skin reactions (blisters, peeling rash, mouth sores)
- Visual problems (eye pain, vision changes, swelling around eyes)
- Seizures or convulsions
- Urinary retention (decreased flow or inability to urinate)
- Manic episodes
Discontinuation Symptoms
Stopping duloxetine too quickly causes withdrawal symptoms in up to one-third of patients 1:
- Anxiety and irritability
- Fatigue and sleep problems
- Headache
- Sweating and dizziness
- Electric shock-like sensations
- Nausea, vomiting, diarrhea
Pediatric Considerations
In children and adolescents 1:
- Most common side effects: nausea, decreased weight, dizziness
- Height and weight should be monitored during treatment
- Adult side effects may also occur
Important Drug Interactions
Avoid or use with extreme caution 1:
- MAOIs (contraindicated)
- Thioridazine (can cause serious heart rhythm problems or sudden death)
- Potent CYP1A2 inhibitors (ciprofloxacin, enoxacin)
- Other serotonergic drugs (see serotonin syndrome above)
Use with caution 1:
- Drugs metabolized by CYP2D6, especially those with narrow therapeutic index
- Blood thinners (warfarin)
- NSAIDs and aspirin
Clinical Considerations
Diabetes-Specific Warning
- In longer-term studies, duloxetine caused a small increase in A1C compared to placebo in patients with diabetes 3, 2
Pregnancy and Breastfeeding
- Notify healthcare provider immediately if pregnant or planning pregnancy 1
- Duloxetine passes into breast milk and may harm the baby—discuss feeding options with provider 1